BCX 1470 is a potent and selective Serine protease inhibitor. CX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro, also blocked development of RPA-induced edema in the rat. BCX 1470 may be useful as an anti-inflammatory agent in diseases where complement activation is known to be detrimental.
MedKoo Cat#: 526707
Name: BCX-1470
CAS#: 217099-43-9 (free
Chemical Formula: C14H10N2O2S2
Exact Mass: 302.0184
Molecular Weight: 302.37
Elemental Analysis: C, 55.61; H, 3.33; N, 9.26; O, 10.58; S, 21.21
The following data is based on the product molecular weight 302.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
